These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32896584)

  • 1. Survival Outcomes in Neoadjuvant Chemotherapy for High-grade Upper Tract Urothelial Carcinoma: A Nationally Representative Analysis.
    Khan AI; Taylor BL; Al Hussein Al Awamlh B; Posada Calderon L; Fainberg J; Elahjji R; Shoag J; Scherr DS
    Urology; 2020 Dec; 146():158-167. PubMed ID: 32896584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy.
    Fletcher SA; Pallauf M; Watts EK; Lombardo KA; Campbell JA; Rezaee ME; Rouprêt M; Boorjian SA; Potretzke AM; Roshandel MR; Ploussard G; Djaladat H; Ghoreifi A; Mari A; Campi R; Khene ZE; Raman JD; Kikuchi E; Rink M; Abdollah F; Boormans JL; Fujita K; D'Andrea D; Soria F; Breda A; Hoffman-Censits J; McConkey DJ; Shariat SF; Pradere B; Singla N
    Eur Urol Oncol; 2024 Oct; 7(5):1061-1068. PubMed ID: 38262800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two cycles of neoadjuvant chemotherapy improves survival in patients with high-risk upper tract urothelial carcinoma.
    Zennami K; Sumitomo M; Takahara K; Nukaya T; Takenaka M; Fukaya K; Ichino M; Fukami N; Sasaki H; Kusaka M; Shiroki R
    BJU Int; 2021 Mar; 127(3):332-339. PubMed ID: 32896105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
    Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
    Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Neoadjuvant Chemotherapy on Pathologic Response in Patients With Upper Tract Urothelial Carcinoma Undergoing Extirpative Surgery.
    Almassi N; Gao T; Lee B; Stein RJ; Haber GP; Ornstein MC; Rini BI; Gilligan TD; Garcia JA; Stephenson AJ; Grivas P
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1237-e1242. PubMed ID: 30217764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract.
    Nazzani S; Preisser F; Mazzone E; Tian Z; Mistretta FA; Shariat SF; Soulières D; Saad F; Montanari E; Luzzago S; Briganti A; Carmignani L; Karakiewicz PI
    World J Urol; 2019 Jul; 37(7):1329-1337. PubMed ID: 30298285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing the Sequence of Chemotherapy for Upper Tract Urothelial Carcinoma with Clinically Positive Regional Lymph Nodes.
    Chakiryan N; Martinez A; Gao L; Liu JJ; Amling C; Garzotto M; Kopp RP
    J Urol; 2019 Jul; 202(1):76-82. PubMed ID: 30925108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma.
    Margulis V; Puligandla M; Trabulsi EJ; Plimack ER; Kessler ER; Matin SF; Godoy G; Alva A; Hahn NM; Carducci MA; Hoffman-Censits J;
    J Urol; 2020 Apr; 203(4):690-698. PubMed ID: 31702432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry.
    Tuderti G; Mastroianni R; Proietti F; Wu Z; Wang L; Franco A; Abdollah F; Finati M; Ferro M; Tozzi M; Porpiglia F; Checcucci E; Bhanvadia R; Margulis V; Bronimann S; Singla N; Hakimi K; Derweesh IH; Correa A; Helstrom E; Mendiola DF; Gonzalgo ML; David RB; Mehrazin R; Moon SC; Rais-Bahrami S; Yong C; Sundaram CP; Tufano A; Perdonà S; Ghoreifi A; Moghaddam FS; Djaladat H; Ditonno F; Antonelli A; Autorino R; Simone G
    World J Urol; 2024 Oct; 42(1):575. PubMed ID: 39395052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy increases survival and downstaging of upper tract urothelial cancer.
    Davaro F; May A; McFerrin C; Raza SJ; Siddiqui S; Hamilton Z
    Can J Urol; 2019 Oct; 26(5):9938-9944. PubMed ID: 31629443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: A systematic review and meta-analysis.
    Kim DK; Lee JY; Kim JW; Hah YS; Cho KS
    Crit Rev Oncol Hematol; 2019 Mar; 135():59-65. PubMed ID: 30819447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic stage as a surrogate for oncologic outcomes after receipt of neoadjuvant chemotherapy for high-grade upper tract urothelial carcinoma.
    Singla N; Christie A; Freifeld Y; Ghandour RA; Woldu SL; Clinton TN; Petros FG; Robyak H; Yeh HC; Fang D; Enikeev D; Bagrodia A; Sagalowsky AI; Lotan Y; Raman JD; Matin SF; Margulis V
    Urol Oncol; 2020 Dec; 38(12):933.e7-933.e12. PubMed ID: 32430254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.
    D'Andrea D; Matin S; Black PC; Petros FG; Zargar H; Dinney CP; Cookson MS; Kassouf W; Dall'Era MA; McGrath JS; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; Sridhar SS; North S; Barocas DA; Lotan Y; Stephenson AJ; van Rhijn BW; Spiess PE; Daneshmand S; Shariat SF
    BJU Int; 2021 May; 127(5):528-537. PubMed ID: 32981193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma.
    Martini A; Falagario UG; Waingankar N; Daza J; Treacy PJ; Necchi A; Galsky MD; Sfakianos JP
    Urol Oncol; 2020 Aug; 38(8):684.e9-684.e15. PubMed ID: 32284255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma.
    Pradere B; D'Andrea D; Schuettfort VM; Foerster B; Quhal F; Mori K; Abufaraj M; Margulis V; Deuker M; Briganti A; Muilwijk T; Hendricksen K; Lotan Y; Karakiewic P; F Shariat S;
    World J Urol; 2021 Jul; 39(7):2567-2577. PubMed ID: 33067726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicentre retrospective study.
    Hamaya T; Hatakeyama S; Tanaka T; Kubota Y; Togashi K; Hosogoe S; Fujita N; Kusaka A; Tokui N; Okamoto T; Yamamoto H; Yoneyama T; Yoneyama T; Hashimoto Y; Ohyama C
    BJU Int; 2021 Oct; 128(4):468-476. PubMed ID: 33484231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Response Rates to Neoadjuvant Chemotherapy in High-Grade Upper Tract Urothelial Carcinoma.
    Meng X; Chao B; Vijay V; Silver H; Margolin EJ; Balar A; Taneja SS; Shah O; Bjurlin MA; Anderson CB; Huang WC
    Urology; 2019 Jul; 129():146-152. PubMed ID: 30930207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration.
    Necchi A; Lo Vullo S; Mariani L; Moschini M; Hendricksen K; Rink M; Sosnowski R; Dobruch J; Raman JD; Wood CG; Margulis V; Roupret M; Briganti A; Montorsi F; Xylinas E; Shariat SF;
    BJU Int; 2018 Feb; 121(2):252-259. PubMed ID: 28940605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma.
    Porten S; Siefker-Radtke AO; Xiao L; Margulis V; Kamat AM; Wood CG; Jonasch E; Dinney CP; Matin SF
    Cancer; 2014 Jun; 120(12):1794-9. PubMed ID: 24633966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephroureterectomy vs. segmental ureterectomy of clinically localized, high-grade, urothelial carcinoma of the ureter: Practice patterns and outcomes.
    Piraino JA; Snow ZA; Edwards DC; Hager S; McGreen BH; Diorio GJ
    Urol Oncol; 2020 Nov; 38(11):851.e1-851.e10. PubMed ID: 32859461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.